HANDOK Inc. (002390.KS)
KRW 12270.0
(-2.54%)
KRW 12270.0
(-2.54%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 94.46 Billion KRW | 2.16% |
| 2022 | 92.46 Billion KRW | 9.95% |
| 2021 | 84.09 Billion KRW | 0.43% |
| 2020 | 83.73 Billion KRW | -11.58% |
| 2019 | 94.69 Billion KRW | 22.98% |
| 2018 | 77 Billion KRW | 12.95% |
| 2017 | 68.17 Billion KRW | -4.81% |
| 2016 | 71.61 Billion KRW | 32.99% |
| 2015 | 53.85 Billion KRW | -8.86% |
| 2014 | 59.08 Billion KRW | 3.11% |
| 2013 | 57.29 Billion KRW | 3.87% |
| 2012 | 55.16 Billion KRW | 14.7% |
| 2011 | 48.09 Billion KRW | -17.28% |
| 2010 | 58.13 Billion KRW | 38.72% |
| 2009 | 41.91 Billion KRW | -7.82% |
| 2008 | 45.46 Billion KRW | 6.2% |
| 2007 | 42.81 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 98.16 Billion KRW | 3.92% |
| 2024 Q2 | 102.53 Billion KRW | 4.45% |
| 2023 Q4 | 94.46 Billion KRW | 0.12% |
| 2023 Q1 | 89.05 Billion KRW | -3.69% |
| 2023 Q3 | 94.35 Billion KRW | 3.87% |
| 2023 Q2 | 90.84 Billion KRW | 2.01% |
| 2023 FY | 94.46 Billion KRW | 2.16% |
| 2022 Q1 | 116.81 Billion KRW | 38.9% |
| 2022 Q2 | 109.03 Billion KRW | -6.66% |
| 2022 FY | 92.46 Billion KRW | 9.95% |
| 2022 Q4 | 92.46 Billion KRW | -6.94% |
| 2022 Q3 | 99.36 Billion KRW | -8.87% |
| 2021 Q2 | 106.15 Billion KRW | -5.16% |
| 2021 Q3 | 101.58 Billion KRW | -4.31% |
| 2021 FY | 84.09 Billion KRW | 0.43% |
| 2021 Q1 | 111.93 Billion KRW | 33.67% |
| 2021 Q4 | 84.09 Billion KRW | -17.21% |
| 2020 Q4 | 83.73 Billion KRW | -14.9% |
| 2020 FY | 83.73 Billion KRW | -11.58% |
| 2020 Q1 | 98.86 Billion KRW | 4.4% |
| 2020 Q3 | 98.39 Billion KRW | -0.35% |
| 2020 Q2 | 98.74 Billion KRW | -0.12% |
| 2019 Q2 | 93.97 Billion KRW | 10.46% |
| 2019 FY | 94.69 Billion KRW | 22.98% |
| 2019 Q4 | 94.69 Billion KRW | -2.74% |
| 2019 Q3 | 97.36 Billion KRW | 3.61% |
| 2019 Q1 | 85.07 Billion KRW | 10.49% |
| 2018 Q1 | 67.63 Billion KRW | -0.8% |
| 2018 Q4 | 77 Billion KRW | 0.56% |
| 2018 Q3 | 76.56 Billion KRW | 11.09% |
| 2018 FY | 77 Billion KRW | 12.95% |
| 2018 Q2 | 68.92 Billion KRW | 1.91% |
| 2017 Q2 | 80.28 Billion KRW | -0.28% |
| 2017 Q3 | 75.83 Billion KRW | -5.55% |
| 2017 Q4 | 68.17 Billion KRW | -10.1% |
| 2017 FY | 68.17 Billion KRW | -4.81% |
| 2017 Q1 | 80.51 Billion KRW | 12.43% |
| 2016 Q1 | 59.58 Billion KRW | 10.64% |
| 2016 Q3 | 73.4 Billion KRW | 7.61% |
| 2016 Q4 | 71.61 Billion KRW | -2.44% |
| 2016 FY | 71.61 Billion KRW | 32.99% |
| 2016 Q2 | 68.21 Billion KRW | 14.49% |
| 2015 FY | 53.85 Billion KRW | -8.86% |
| 2015 Q4 | 53.85 Billion KRW | 0.0% |
| 2014 Q1 | 62.38 Billion KRW | 8.88% |
| 2014 FY | 59.08 Billion KRW | 3.11% |
| 2014 Q2 | 64.79 Billion KRW | 3.85% |
| 2014 Q3 | 67.03 Billion KRW | 3.46% |
| 2013 Q1 | 51.95 Billion KRW | -5.83% |
| 2013 Q3 | 58.6 Billion KRW | 6.93% |
| 2013 Q4 | 57.29 Billion KRW | -2.23% |
| 2013 FY | 57.29 Billion KRW | 3.87% |
| 2013 Q2 | 54.81 Billion KRW | 5.5% |
| 2012 Q4 | 55.16 Billion KRW | 0.0% |
| 2012 FY | 55.16 Billion KRW | 14.7% |
| 2012 Q1 | 56.3 Billion KRW | 0.0% |
| 2011 FY | 48.09 Billion KRW | -17.28% |
| 2011 Q3 | 56.8 Billion KRW | 14.08% |
| 2011 Q2 | 49.79 Billion KRW | 1.67% |
| 2011 Q1 | 48.97 Billion KRW | -15.76% |
| 2010 Q4 | 58.13 Billion KRW | -27.23% |
| 2010 FY | 58.13 Billion KRW | 38.72% |
| 2010 Q2 | 68.17 Billion KRW | 9.07% |
| 2010 Q3 | 79.89 Billion KRW | 17.2% |
| 2010 Q1 | 62.5 Billion KRW | 49.13% |
| 2009 Q3 | 43.46 Billion KRW | 19.48% |
| 2009 Q2 | 36.38 Billion KRW | -35.18% |
| 2009 Q4 | 41.91 Billion KRW | -3.59% |
| 2009 Q1 | 56.12 Billion KRW | 23.46% |
| 2009 FY | 41.91 Billion KRW | -7.82% |
| 2008 Q2 | 39.43 Billion KRW | -10.33% |
| 2008 Q1 | 43.97 Billion KRW | 2.72% |
| 2008 Q3 | 50.67 Billion KRW | 28.5% |
| 2008 FY | 45.46 Billion KRW | 6.2% |
| 2008 Q4 | 45.46 Billion KRW | -10.27% |
| 2007 Q2 | 32.69 Billion KRW | -16.13% |
| 2007 Q1 | 38.98 Billion KRW | 0.0% |
| 2007 Q3 | 36.75 Billion KRW | 12.42% |
| 2007 FY | 42.81 Billion KRW | 0.0% |
| 2007 Q4 | 42.81 Billion KRW | 16.47% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -113.952% |
| Dong-A Socio Holdings Co., Ltd. | 117.85 Billion KRW | 19.845% |
| Ildong Holdings Co., Ltd. | 91.16 Billion KRW | -3.618% |
| Kukje Pharma Co., Ltd. | 21.24 Billion KRW | -344.684% |
| Yuhan Corporation | 284.75 Billion KRW | 66.826% |
| Dong-A ST Co., Ltd. | 116.31 Billion KRW | 18.785% |
| SAMSUNG PHARM. Co., LTD. | 16.25 Billion KRW | -481.01% |
| Hanmi Pharm. Co., Ltd. | 288.81 Billion KRW | 67.292% |
| Hanall Biopharma Co.,Ltd | 32.38 Billion KRW | -191.7% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -53.042% |
| Dong Sung Bio Pharm.Co.,Ltd. | 19.47 Billion KRW | -385.004% |
| MYUNGMOON Pharm co.,Ltd | 30.28 Billion KRW | -211.968% |
| Hana Pharm Co., Ltd. | 48.34 Billion KRW | -95.387% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -113.952% |
| Ilsung Pharmaceuticals Co., Ltd. | 31.24 Billion KRW | -202.376% |
| REYON Pharmaceutical Co., Ltd. | 35.17 Billion KRW | -168.545% |
| Aprogen pharmaceuticals,Inc. | 48.12 Billion KRW | -96.277% |
| JW Holdings Corporation | 147.58 Billion KRW | 35.995% |
| Ildong Pharmaceutical Co., Ltd. | 84.62 Billion KRW | -11.629% |
| Chong Kun Dang Pharmaceutical Corp. | 261.43 Billion KRW | 63.866% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 10.959% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -75.183% |
| Hyundai Pharmaceutical Co., Ltd. | 26.99 Billion KRW | -249.895% |
| Samil Pharmaceutical Co.,Ltd | 32.51 Billion KRW | -190.558% |
| Jeil Pharmaceutical Co.,Ltd | 109.76 Billion KRW | 13.942% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -113.952% |
| Kwang Dong Pharmaceutical Co., Ltd. | 188.64 Billion KRW | 49.924% |
| Daewoong pharmaceutical Co.,Ltd | 241.54 Billion KRW | 60.892% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 10.959% |
| Yuhan Corporation | 284.75 Billion KRW | 66.826% |
| Jeil Pharma Holdings Inc | 125.28 Billion KRW | 24.597% |
| Yungjin Pharm. Co., Ltd. | 61.98 Billion KRW | -52.395% |
| Suheung Co., Ltd. | 259.84 Billion KRW | 63.645% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | 10.959% |
| Samjin Pharmaceuticals Co., Ltd. | 79.6 Billion KRW | -18.67% |
| Korea United Pharm Inc. | 49.14 Billion KRW | -92.228% |
| CKD Bio Corp. | 69.08 Billion KRW | -36.742% |
| Daewon Pharmaceutical Co., Ltd. | 105.07 Billion KRW | 10.101% |
| Dongwha Pharm.Co.,Ltd | 70.69 Billion KRW | -33.619% |
| Whan In Pharm Co.,Ltd. | 54.05 Billion KRW | -74.747% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -75.183% |
| Chong Kun Dang Holdings Corp. | 194.76 Billion KRW | 51.498% |
| Boryung Corporation | 189.8 Billion KRW | 50.231% |
| Bukwang Pharmaceutical Co., Ltd. | 56.83 Billion KRW | -66.218% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -53.042% |
| JW Lifescience Corporation | 23.39 Billion KRW | -303.719% |